PIR and cancer: Several studies have indicated that tumor cells escape CD8+ (cytotoxic) T cells in tumor microenvironment by decreasing their own FAS expression or acquiring lose‐of‐function mutations of components in FAS death pathway.[21] To this end, we turn to explore whether PIR functions in cancer cells in avoiding immunosurveillance.